Trademark: 90832349
Status Date
Wednesday, January 17, 2024
Filing Date
Friday, July 16, 2021
Published for Opposition
Tuesday, June 21, 2022
5 pharmaceuticals and therapeutic pharmaceuticals for the treatment of neurological conditions; pharmaceuticals and therapeutic pharmaceuticals for the treatment and prevention of immunological conditions; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer; pharmaceuticals and therapeutic pharmaceuticals for the treatment and prevention of ophthalmic conditions
42 research and development of pharmaceuticals and therapeutics in the fields of neurology, immunology, oncology and ophthalmology
The English translation of ALIADA in the mark is ALLIED.
"THERAPEUTICS"
Jan 19, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2024
Sou Extension 3 Granted
Jan 17, 2024
Sou Extension 3 Filed
Jan 17, 2024
Sou Teas Extension Received
Jul 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 15, 2023
Sou Extension 2 Granted
Jul 15, 2023
Sou Extension 2 Filed
Jul 15, 2023
Sou Teas Extension Received
Jan 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2023
Sou Extension 1 Granted
Jan 5, 2023
Sou Extension 1 Filed
Jan 5, 2023
Sou Teas Extension Received
Aug 16, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 21, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2022
Published For Opposition
Jun 1, 2022
Notification Of Notice Of Publication E-Mailed
May 13, 2022
Approved For Pub - Principal Register
May 11, 2022
Teas/Email Correspondence Entered
May 11, 2022
Correspondence Received In Law Office
May 11, 2022
Teas Response To Office Action Received
Apr 14, 2022
Notification Of Non-Final Action E-Mailed
Apr 14, 2022
Non-Final Action E-Mailed
Apr 14, 2022
Non-Final Action Written
Apr 7, 2022
Assigned To Examiner
Sep 20, 2021
New Application Office Supplied Data Entered
Jul 20, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
